Andrew D Weeks, Caroline Cunningham, Wendy Taylor, Anna Rosala-Hallas, Peter Watt, Lucy Bryning, Victory Ezeofor, Liz Cregan, Emma Hayden, Dot Lambert, Carol Bedwell, Steven Lane, Tony Fisher, Rhiannon T Edwards, Tina Lavender
BACKGROUND: We evaluated the safety, efficacy, and acceptability of a new device designed to facilitate uterine compression in women with postpartum haemorrhage (PPH). METHODS: A prospective, phase two clinical device trial with concurrent qualitative study, conducted in a UK consultant obstetric unit. The device was used in addition to standard care in women unresponsive to initial oxytocin therapy. The primary effectiveness outcome was additional blood loss of over 1000mls, whilst safety was assessed through adverse events...
April 2023: European Journal of Obstetrics, Gynecology, and Reproductive Biology